ArticleInternational ophthalmology2025
Clinical observation on the repair of inferomedial eyelid defects with temporal island flaps pedicled with the orbicularis oculi muscle.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe repair of Lower eyelid defect is a medical challenge for plastic surgeons. Objective to investigate the clinical effect of repairing inferomedial eyelid defects with temporal island flaps pedicled with the orbicularis oculi muscle.
methodsA retrospective analysis was conducted on 12 cases of inferomedial eyelid defects caused by tumors, scars or other reasons, in The First Affiliated Hospital of Anhui Medical University from January 2021 to October 2022. Temporal island flaps pedicled with the orbicularis oculi muscle or traditional nasolabial fold flaps were used to repair the inferomedial eyelid defects, and the patients were followed up for 2 to 13 months to observe postoperative tumor residue, scar release degree, flap survival, lower eyelid ectropion. Descriptive statistical methods were used to evaluate the treatment effect.
resultsIn 11 out of 12 patients, the tumors were completely resected with no residual at the margins and bases. In 1 patient with lower eyelid ectropion, it was completely corrected, which the scar was completely released and the lower eyelid was restored. The flaps in all 12 patients survived completely, and in one case, there was partial epidermal necrosis, which healed after dressing change and delayed healing. One patient designed the nasolabial V-Y advancement flap developed eyelid ectropion and retraction. During the follow-up period of 2 to 13 months, no lower eyelid ectropion or epiphora occurred.
conclusionThe orbicularis oculi muscle-pedicled temporal island flap demonstrates significant clinical efficacy in reconstructing inferomedial eyelid defects, particularly due to its combination of surgical practicality and favorable tissue characteristics. This technique offers three distinct advantages: (1) straightforward surgical preparation with minimal donor site morbidity, (2) optimal tissue compatibility through preserved eyelid texture and robust vascular supply, and (3) enhanced rotational capacity and generous flap dimensions. LEVEL OF EVIDENCE: Level IV, therapeutic study.
Indexed as
Identifiers
40504433What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.